Annual accounts receivable:
$73.07M+$47.26M(+183.12%)Summary
- As of today (September 3, 2025), ARQT annual accounts receivable is $73.07 million, with the most recent change of +$47.26 million (+183.12%) on December 31, 2024.
- During the last 3 years, ARQT annual accounts receivable has risen by +$73.07 million (+100.00%).
- ARQT annual accounts receivable is now at all-time high.
Performance
ARQT Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$106.69M+$21.27M(+24.91%)Summary
- As of today (September 3, 2025), ARQT quarterly accounts receivable is $106.69 million, with the most recent change of +$21.27 million (+24.91%) on June 30, 2025.
- Over the past year, ARQT quarterly accounts receivable has increased by +$63.28 million (+145.76%).
- ARQT quarterly accounts receivable is now at all-time high.
Performance
ARQT Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ARQT Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +183.1% | +145.8% |
| 3 y3 years | +100.0% | - |
| 5 y5 years | - | - |
ARQT Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | at high | +4288.6% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ARQT Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $106.69M(+24.9%) |
| Mar 2025 | - | $85.42M(+16.9%) |
| Dec 2024 | $73.07M(+183.1%) | $73.07M(+21.5%) |
| Sep 2024 | - | $60.12M(+38.5%) |
| Jun 2024 | - | $43.41M(+16.8%) |
| Mar 2024 | - | $37.15M(+44.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $25.81M(+205.1%) | $25.81M(+32.9%) |
| Sep 2023 | - | $19.42M(+12.8%) |
| Jun 2023 | - | $17.21M(+34.8%) |
| Mar 2023 | - | $12.77M(+51.0%) |
| Dec 2022 | $8.46M(>+9900.0%) | $8.46M(+247.9%) |
| Sep 2022 | - | $2.43M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual accounts receivable year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly accounts receivable year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual accounts receivable?
The current annual accounts receivable of ARQT is $73.07M
What is the all time high annual accounts receivable for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual accounts receivable is $73.07M
What is Arcutis Biotherapeutics, Inc. annual accounts receivable year-on-year change?
Over the past year, ARQT annual accounts receivable has changed by +$47.26M (+183.12%)
What is Arcutis Biotherapeutics, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of ARQT is $106.69M
What is the all time high quarterly accounts receivable for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly accounts receivable is $106.69M
What is Arcutis Biotherapeutics, Inc. quarterly accounts receivable year-on-year change?
Over the past year, ARQT quarterly accounts receivable has changed by +$63.28M (+145.76%)